Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection (2019)
Attributed to:
MRC Centre for Molecular Bacteriology and Infection
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejpb.2018.10.020
PubMed Identifier: 30385419
Publication URI: http://europepmc.org/abstract/MED/30385419
Type: Journal Article/Review
Parent Publication: European Journal of Pharmaceutics and Biopharmaceutics
ISSN: 0939-6411